Dr. Ellis on Resistance to Endocrine Therapy in HR+ Metastatic Breast Cancer

13 Jul 2018 01:52 0
90
2 0

Matthew J. Ellis, MD, PhD, professor and director, Lester and Sue Smith Breast Center, associate director of precision medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, discusses resistance to endocrine therapy in hormone receptor (HR)-positive breast cancer.

Related of "Dr. Ellis on Resistance to Endocrine Therapy in HR+ Metastatic Breast Cancer" Videos